HPSE2 Mutations in Urofacial Syndrome, Non-Neurogenic Neurogenic Bladder and Lower Urinary Tract Dysfunction

dc.contributor.authorBulum, Burcu
dc.contributor.authorOzcakar, Z. Birsin
dc.contributor.authorDuman, Duygu
dc.contributor.authorCengiz, Filiz Basak
dc.contributor.authorKavaz, Asli
dc.contributor.authorBurgu, Berk
dc.contributor.authorBaskin, Esra
dc.contributor.authorCakar, Nilgun
dc.contributor.authorSoygur, Tarkan
dc.contributor.authorEkim, Mesiha
dc.contributor.authorTekin, Mustafa
dc.contributor.authorYalcinkaya, Fatos
dc.contributor.orcID0000-0003-4361-8508en_US
dc.contributor.pubmedID25924634en_US
dc.contributor.researcherIDB-5785-2018en_US
dc.date.accessioned2024-02-05T07:55:30Z
dc.date.available2024-02-05T07:55:30Z
dc.date.issued2015
dc.description.abstractBackground: Urofacial syndrome (UFS) is characterised by congenital bladder dysfunction accompanied by a characteristic abnormal grimace upon smiling and crying. In recent years, biallelic mutations of HPSE2 and LRIG2 have been reported in UFS patients. Non-neurogenic neurogenic bladder (NNNB) has a bladder identical to UFS without typical facial features. The aim of this study was to analyse HPSE2 mutations in patients with UFS and NNNB or severe lower urinary tract dysfunction (LUTD) without abnormal facial expression. Methods: Patients with UFS, NNNB and severe LUTD were enrolled in the study. We examined a total of 35 patients from 33 families. There were seven UFS patients from five different families, 21 patients with NNNB and seven with LUTD. HPSE2 gene mutation analysis was performed using the polymerase chain reaction protocol followed by Sanger sequencing in these patients. Results: A twin pair with UFS was found to be homozygous for c.457C>T (p.Arg153*) mutation. No other pathogenetic variant was detected. Conclusion: HPSE2 mutations were found in one UFS family but not detected in patients with NNNB and severe LUTD. Considering the increasingly recognised cases of NNNB that were diagnosed in early childhood period, genetic factors appear to be responsible. Thus, further genetic studies are needed to discover novel associated gene variants in these bladder anomalies. (C) 2015 S. Karger AG, Baselen_US
dc.identifier.eissn2235-3186en_US
dc.identifier.endpage58en_US
dc.identifier.issn1660-8151en_US
dc.identifier.issue1en_US
dc.identifier.scopus2-s2.0-84965145813en_US
dc.identifier.startpage54en_US
dc.identifier.urihttp://hdl.handle.net/11727/11421
dc.identifier.volume130en_US
dc.identifier.wos000355772500009en_US
dc.language.isoengen_US
dc.relation.isversionof10.1159/000381465en_US
dc.relation.journalNEPHRONen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergien_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectChildrenen_US
dc.subjectHPSE2 gene mutationsen_US
dc.subjectLower urinary tract dysfunctionen_US
dc.subjectNon-neurogenic neurogenic bladderen_US
dc.subjectUrofacial (Ochoa) syndromeen_US
dc.titleHPSE2 Mutations in Urofacial Syndrome, Non-Neurogenic Neurogenic Bladder and Lower Urinary Tract Dysfunctionen_US
dc.typearticleen_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: